Genesco raises FY27 GAAP EPS guidance to $2.96-$3.39 on margin gains
- Genesco raises FY27 GAAP diluted EPS guidance to $2.96-$3.39 from $2.32-$2.75
- Q2 net sales fell 3% to $530 million, beating consensus of $527.26 million
- Adjusted gross margin expanded 140 bps to 47.2% on higher full-price selling
- Full-year comparable sales guidance lowered to flat from 1%-2% positive

*this image is generated using AI for illustrative purposes only.
Genesco Inc. (NYSE: GCO) reported second quarter Fiscal 2027 results for the three months ended August 1, 2026, raising its full-year GAAP diluted EPS guidance to $2.96-$3.39 from the previous range of $2.32-$2.75. This updated outlook significantly exceeds the $2.24 analyst estimate.
Key Financial Highlights
Net sales for Q2FY27 declined 3% to $530 million from $546 million in Q2FY26. The reported sales figure of $529.858 million beat the analyst consensus estimate of $527.260 million by 0.49 percent. The decrease reflected net store closures, reduced licensed sales, a 6% drop in e-commerce comparable sales from reduced Schuh discounting, and an unfavorable foreign exchange impact, partially offset by a 1% increase in same-store sales and higher sales from enlarged stores.
The following table summarises key income statement metrics for the quarter:
| Metric | Q2FY27 | Q2FY26 |
|---|---|---|
| Net Sales | $530 million | $546 million |
| Gross Margin % (GAAP) | 51.4% | 45.8% |
| Adjusted Gross Margin % | 47.2% | 45.8% |
| Selling & Admin Expenses % | 49.0% | 48.4% |
| GAAP Operating Income (Loss) | $3.6 million (0.7% of sales) | ($14.4 million) (-2.6% of sales) |
| Adjusted Operating Loss | ($8.3 million) (-1.6% of sales) | ($14.3 million) (-2.6% of sales) |
| GAAP Diluted EPS | $0.32 | ($1.79) |
| Non-GAAP Diluted EPS | ($0.83) | ($1.14) |
Gross margin improved 560 basis points on a GAAP basis, reflecting tariff refunds. Adjusted gross margin improved 140 basis points, driven by less promotional activity and higher full-price selling at Schuh, favorable sales mix changes, license exit benefit, and pricing and tariff mitigation actions across branded businesses.
GAAP earnings from continuing operations were $3.5 million in Q2FY27, compared to a loss of $18.5 million in Q2FY26. Adjusted loss from continuing operations was $8.8 million, or $0.83 per share, versus a loss of $11.7 million, or $1.14 per share, in the prior-year quarter.
Comparable Sales by Segment
Journeys Group delivered its eighth consecutive quarter of positive total comparable sales growth. The table below shows comparable sales performance by segment:
| Segment | 2QFY27 | 2QFY26 |
|---|---|---|
| Journeys Group | 2% | 9% |
| Schuh Group | (9)% | (4)% |
| Johnston & Murphy Group | 4% | 1% |
| Total Genesco Comparable Sales | (1)% | 4% |
| Same Store Sales | 1% | 5% |
| Comparable E-commerce Sales | (6)% | 1% |
The overall 3% sales decline was driven by a 10% decrease at Schuh and a 21%, or $7 million, decrease at Genesco Brands, partially offset by a 5% increase at Johnston & Murphy, while Journeys sales were flat. On a constant currency basis, Schuh sales were also down 10%.
Tariff Refunds and Cost Savings
The company received $22.5 million in tariff refunds, including interest, during the second quarter related to its branded businesses under the International Emergency Economic Powers Act. These refunds are excluded from adjusted results. No additional tariff refunds are included in the company's full-year guidance.
In connection with its IT Transformation and programs to drive automation, operating efficiencies, and spend optimization, the company announced a cost reduction program expected to generate savings of $40 to $50 million between now and Fiscal 2029, with up to $20 million realized in the current fiscal year.
Balance Sheet and Store Activity
Cash as of August 1, 2026 was $57.1 million, compared with $41.0 million as of August 2, 2025. Total debt at the end of Q2FY27 was $15.8 million versus $71.0 million at the end of Q2FY26. Inventories increased 8% year-over-year, primarily reflecting increased inventory at Journeys.
Capital expenditures for the quarter were $17 million, primarily related to retail store remodels. Depreciation and amortization was $13 million. The company opened three stores and closed 25 stores during the quarter, ending with 1,186 stores compared with 1,253 stores at the end of Q2FY26, a decrease of 5%. Square footage was also down 5% year-over-year.
The company did not repurchase any shares during Q2FY27. As of August 31, 2026, 317,503 shares had been repurchased in the third quarter, with $18.8 million remaining on its expanded share repurchase authorization announced in June 2023.
Fiscal 2027 Outlook
Based on better-than-expected Q2FY27 results, the company updated its full-year outlook. Key guidance updates are as follows:
- Genesco affirms FY2027 adjusted diluted EPS guidance of $2.00 to $2.40 versus the $2.25 analyst estimate. This represents the high end of the range versus the midpoint in prior guidance.
- Genesco raises FY2027 GAAP diluted EPS guidance to $2.96-$3.39 from the previous range of $2.32-$2.75, versus the $2.24 analyst estimate.
- Comparable sales now expected to be flat, versus prior guidance of positive 1% to 2%, reflecting greater pressure at Schuh.
- Total sales now expected down approximately 2% to $2.387 billion, lowering the previous range of $2.412 billion to $2.436 billion. This is below the $2.430 billion analyst estimate.
- Operating income now expected at the high end of the previous range of $34 to $40 million, versus the prior view of the midpoint.
- Guidance reflects repurchases through August 31 and assumes no further share repurchases for the year; tax rate assumed at 30% for Fiscal 2027, with Q3FY27 tax rate in the range of approximately 7% to 8%
What the Numbers Show
The significant upward revision in GAAP EPS guidance to $2.96-$3.39 contrasts sharply with the lowered sales outlook and affirmed adjusted EPS guidance of $2.00-$2.40. While the core business remains under pressure, evidenced by the flat comparable sales expectation and 2% decline in total sales, the GAAP beat is likely driven by non-recurring items such as the previously disclosed tariff refunds and specific tax assumptions (30% annual rate vs 7-8% in Q3). The divergence between the strong GAAP EPS raise and the weak top-line guidance highlights that profitability improvements are currently structural or one-off rather than operational revenue growth.
How sustainable is Genesco's margin expansion strategy if future quarters do not include similar one-time tariff refunds or license exit benefits?
What specific operational changes is Genesco implementing to reverse the 9% comparable sales decline at Schuh and stabilize its European footprint?
Will the $40-$50 million in projected cost savings from IT transformation and automation be sufficient to offset the anticipated 2% decline in total sales for Fiscal 2027?






























